Lycorine protects against septic myocardial injury by activating AMPK-related pathways
Huadong Zhao,Ying Chen,Lu Qian,Luyang Du,Xue Wu,Ye Tian,Chao Deng,Shuai Liu,Wenwen Yang,Chenxi Lu,Yan Zhang,Jun Ren,Yang Yang
DOI: https://doi.org/10.1016/j.freeradbiomed.2023.01.010
IF: 8.101
2023-03-01
Free Radical Biology and Medicine
Abstract:Cardiac dysfunction is a common complication in patients with sepsis triggering high morbidity and mortality. Lycorine (LYC), the main effective monomer component extracted from Lycoris bulbs, possesses antiviral, anti-inflammatory, analgesic, liver protection properties. In this study, the effect of LYC pre- and post-treatment as well as the underlying mechanism were evaluated in the cecal ligation and puncture (CLP) model of Balb/c mice. The survival rate, anal temperature, sepsis score, blood biochemical/routine indicators, cardiac function, sepsis-related pathophysiological processes, and AMPK signaling in septic mice were observed by echocardiography, histological staining, western blot, qPCR, and etc. LYC pretreatment attenuated myocardial injury in septic mice by improving survival rate, sepsis score, blood biochemical/routine indicators, cardiac function and structure, inhibiting inflammation and oxidative stress, improving mitochondrial function, modulating endoplasmic reticulum stress, and activating AMPK pathway. In particular, AMPK deficiency and AMPK inhibitor (Compound C) partially reversed the protective effects of LYC in septic mice. In addition, LYC posttreatment also has slight protective phenotypes on septic myocardial injury, but the effect is not as ideal as pretreatment. Taken together, these findings suggest that LYC may be a potential drug for the treatment of sepsis.
biochemistry & molecular biology,endocrinology & metabolism